Month: April 2020

FDA discourages Zantac sales over cancer risks

On Behalf of Clark, Love & Hutson | Apr 30, 2020 | Dangerous Drug Litigation

On April 1, the Food and Drug Administration (FDA) urged companies to stop selling all forms of the heartburn drug Zantac after the agency concluded the product could cause cancer due to an agent that builds up when the drug is stored for long periods. The agency also...

More deaths from inclined infant sleepers reported

On Behalf of Clark, Love & Hutson | Apr 20, 2020 | Defective Product Litigation

According to the American Academy of Pediatrics, infants should sleep alone, on their backs, without restraints, on a firm, flat surface free from soft bedding or padded bumpers. Inclined infant sleepers do not conform to these guidelines. They are not flat or firm...